Home/Filings/4/0001415889-23-008248
4//SEC Filing

Mayweg Alexander 4

Accession 0001415889-23-008248

CIK 0001701541other

Filed

May 16, 8:00 PM ET

Accepted

May 17, 9:11 PM ET

Size

5.6 KB

Accession

0001415889-23-008248

Insider Transaction Report

Form 4
Period: 2023-05-16
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-05-16+16,50016,500 total
    Exercise: $1.82Exp: 2033-05-15Common Stock (16,500 underlying)
Footnotes (1)
  • [F1]The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) May 16, 2024 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date.

Issuer

Black Diamond Therapeutics, Inc.

CIK 0001701541

Entity typeother

Related Parties

1
  • filerCIK 0001786260

Filing Metadata

Form type
4
Filed
May 16, 8:00 PM ET
Accepted
May 17, 9:11 PM ET
Size
5.6 KB